Journal Article

Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate

Annarica Calcabrini, José Manuel García-Martínez, Lorena González, Mercedes Julián Tendero, María Teresa Agulló Ortuño, Pasqualina Crateri, Abelardo Lopez-Rivas, Giuseppe Arancia, Pedro González-Porqué and Jorge Martín-Pérez

in Carcinogenesis

Volume 27, issue 8, pages 1699-1712
ISSN: 0143-3334
Published online April 2006 | e-ISSN: 1460-2180 | DOI:
Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Lauryl gallate is an antioxidant food additive showing low toxicity to normal cells. Here, its antiproliferative effect has been studied on three human breast cancer cell lines: estrogen-dependent, wild-type p53, MCF7; estrogen-independent, non-functional p53, MDA-MB-231 and MCF7 ADR, which overexpresses P-glycoprotein (P-gp) and displays a multidrug-resistant phenotype. Lauryl gallate inhibited proliferation and induced cell cycle alterations in all three cell lines without altering P-gp functionality in the drug-resistant cells. A stable arrest in G1 phase was observed in MCF7, while a slow-down of cell cycle progression was induced in the other two cell lines. Lauryl gallate increased p53 expression only in MCF7, and upregulated p21Cip1 and reduced cyclin D1 levels in all three cell lines. The induction of apoptosis, demonstrated by annexin V-FITC labeling, PARP cleavage and mitochondrial membrane depolarization and morphological alterations, were clearly detected in MCF7 ADR and MDA-MB-231 and to a minor extent in MCF7. Overexpression of Bcl-2 in MCF7 ADR cells demonstrated its protective role against morphological alterations and apoptosis. Lauryl gallate induction of p21Cip1 and apoptosis observed in all three cell lines was regulated by Erk1/2 activation. These findings suggest a potential use of lauryl gallate against tumors harboring p53 mutations and drug-resistant phenotypes.

Journal Article.  8538 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.